| 0 |
AICHMOPHOBIA |
1 |
0.5000 |
| 1 |
OVARIAN HYPERSTIMULATION SYNDROME |
696 |
0.2983 |
| 2 |
FEMALE GENITAL TRACT TUBERCULOSIS |
2 |
0.2857 |
| 3 |
ANTRAL FOLLICLE COUNT LOW |
1 |
0.2500 |
| 4 |
INDETERMINATE PREGNANCY TEST RESULT |
1 |
0.2500 |
| 5 |
CYSTOSARCOMA PHYLLODES |
2 |
0.2000 |
| 6 |
HAEMOCONCENTRATION |
19 |
0.1098 |
| 7 |
BLOOD HUMAN CHORIONIC GONADOTROPIN DECREASED |
3 |
0.1071 |
| 8 |
OVARIAN HAEMORRHAGE |
25 |
0.1055 |
| 9 |
OOCYTE HARVEST |
2 |
0.1053 |
| 10 |
PREMATURE OVULATION |
8 |
0.1026 |
| 11 |
PAROVARIAN CYST |
1 |
0.1000 |
| 12 |
OVARIAN ENLARGEMENT |
38 |
0.0992 |
| 13 |
POOR RESPONSE TO OVULATION INDUCTION |
1 |
0.0909 |
| 14 |
MULTIPLE PREGNANCY |
16 |
0.0894 |
| 15 |
OVULATION INDUCTION |
1 |
0.0769 |
| 16 |
CONCENTRIC SCLEROSIS |
1 |
0.0667 |
| 17 |
LATENT TETANY |
1 |
0.0667 |
| 18 |
HETEROTOPIC PREGNANCY |
4 |
0.0635 |
| 19 |
OVARIAN TORSION |
5 |
0.0602 |
| 20 |
PREGNANCY OF UNKNOWN LOCATION |
1 |
0.0588 |
| 21 |
CORNEAL LIGHT REFLEX TEST ABNORMAL |
1 |
0.0588 |
| 22 |
VERTEBROBASILAR ARTERY DISSECTION |
5 |
0.0568 |
| 23 |
OVARIAN HAEMATOMA |
1 |
0.0556 |
| 24 |
INTRACRANIAL ARTERY DISSECTION |
1 |
0.0526 |
| 25 |
ENDOMETRIAL METAPLASIA |
1 |
0.0526 |
| 26 |
FAILED IN VITRO FERTILISATION |
3 |
0.0492 |
| 27 |
HUMAN CHORIONIC GONADOTROPIN NEGATIVE |
1 |
0.0476 |
| 28 |
OVULATION DELAYED |
1 |
0.0476 |
| 29 |
HYDROSALPINX |
4 |
0.0435 |
| 30 |
ENDOMETRIAL HYPOPLASIA |
1 |
0.0417 |
| 31 |
ADNEXAL TORSION |
13 |
0.0410 |
| 32 |
UTERINE HYPERSTIMULATION |
4 |
0.0392 |
| 33 |
ILIAC VEIN THROMBOSIS |
1 |
0.0357 |
| 34 |
BORDERLINE SEROUS TUMOUR OF OVARY |
1 |
0.0323 |
| 35 |
OVARIAN NECROSIS |
2 |
0.0317 |
| 36 |
MASTITIS BACTERIAL |
2 |
0.0312 |
| 37 |
OESTRADIOL ABNORMAL |
2 |
0.0303 |
| 38 |
ABORTION EARLY |
3 |
0.0278 |
| 39 |
BIOCHEMICAL PREGNANCY |
3 |
0.0278 |
| 40 |
BREATH SOUNDS ABSENT |
3 |
0.0273 |
| 41 |
ABORTION COMPLETE |
1 |
0.0270 |
| 42 |
ANTERIOR DISPLACED ANUS |
1 |
0.0263 |
| 43 |
BLOOD OESTROGEN INCREASED |
15 |
0.0255 |
| 44 |
ABORTION MISSED |
32 |
0.0252 |
| 45 |
BLOOD LUTEINISING HORMONE INCREASED |
6 |
0.0244 |
| 46 |
PELVIC FLUID COLLECTION |
17 |
0.0241 |
| 47 |
TWIN PREGNANCY |
20 |
0.0238 |
| 48 |
OESTRADIOL INCREASED |
7 |
0.0233 |
| 49 |
INTESTINAL ADHESION LYSIS |
1 |
0.0227 |
| 50 |
IN VITRO FERTILISATION |
4 |
0.0221 |
| 51 |
PLASMA CELL MASTITIS |
1 |
0.0208 |
| 52 |
PROTEIN S DECREASED |
3 |
0.0203 |
| 53 |
CONJOINED TWINS |
2 |
0.0202 |
| 54 |
KIDNEY ANGIOMYOLIPOMA |
1 |
0.0200 |
| 55 |
BLOOD LUTEINISING HORMONE ABNORMAL |
1 |
0.0196 |
| 56 |
MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY-ASSOCIATED DISEASE |
3 |
0.0195 |
| 57 |
ADNEXA UTERI CYST |
3 |
0.0185 |
| 58 |
PROGESTERONE INCREASED |
2 |
0.0180 |
| 59 |
HEREDITARY DISORDER |
1 |
0.0175 |
| 60 |
ANTI-MUELLERIAN HORMONE LEVEL DECREASED |
1 |
0.0172 |
| 61 |
OVARIAN RUPTURE |
2 |
0.0171 |
| 62 |
OVULATION DISORDER |
2 |
0.0171 |
| 63 |
DRUG EXPOSURE BEFORE PREGNANCY |
17 |
0.0168 |
| 64 |
SEPTUM PELLUCIDUM AGENESIS |
1 |
0.0167 |
| 65 |
CEREBRAL DYSGENESIS |
1 |
0.0167 |
| 66 |
TUBO-OVARIAN ABSCESS |
4 |
0.0164 |
| 67 |
HYPOOSMOLAR STATE |
2 |
0.0163 |
| 68 |
PERITONEAL HAEMORRHAGE |
22 |
0.0159 |
| 69 |
OESTRADIOL DECREASED |
5 |
0.0155 |
| 70 |
BLOOD FOLLICLE STIMULATING HORMONE ABNORMAL |
1 |
0.0154 |
| 71 |
BLIGHTED OVUM |
6 |
0.0153 |
| 72 |
BORDERLINE OVARIAN TUMOUR |
1 |
0.0149 |
| 73 |
PRECIPITATE LABOUR |
1 |
0.0149 |
| 74 |
AMNIORRHEXIS |
1 |
0.0139 |
| 75 |
ABDOMINAL WALL DISORDER |
4 |
0.0137 |
| 76 |
PULMONARY ARTERY ATRESIA |
2 |
0.0137 |
| 77 |
BLADDER TAMPONADE |
4 |
0.0132 |
| 78 |
INGUINAL HERNIA, OBSTRUCTIVE |
1 |
0.0125 |
| 79 |
OVARIAN ADHESION |
1 |
0.0125 |
| 80 |
PROPHYLAXIS |
1 |
0.0122 |
| 81 |
CEREBRAL ARTERY THROMBOSIS |
6 |
0.0117 |
| 82 |
BLOOD OESTROGEN ABNORMAL |
2 |
0.0116 |
| 83 |
PROCEDURAL FAILURE |
2 |
0.0112 |
| 84 |
FALLOPIAN TUBE PERFORATION |
1 |
0.0111 |
| 85 |
HYDROMETRA |
2 |
0.0109 |
| 86 |
CREATINE PHOSPHOKINASE DECREASED |
1 |
0.0105 |
| 87 |
CLINICALLY ISOLATED SYNDROME |
1 |
0.0105 |
| 88 |
ABORTION SPONTANEOUS INCOMPLETE |
1 |
0.0103 |
| 89 |
ECTOPIC PREGNANCY |
31 |
0.0101 |
| 90 |
SUPRAPUBIC PAIN |
5 |
0.0098 |
| 91 |
INFECTIOUS THYROIDITIS |
1 |
0.0098 |
| 92 |
PRODUCT CONTAMINATION WITH BODY FLUID |
2 |
0.0098 |
| 93 |
ANOVULATORY CYCLE |
2 |
0.0097 |
| 94 |
HAEMATOCRIT INCREASED |
22 |
0.0096 |
| 95 |
EXTREMITY CONTRACTURE |
6 |
0.0094 |
| 96 |
CHOROIDAL NEOVASCULARISATION |
8 |
0.0093 |
| 97 |
POSTPARTUM DISORDER |
1 |
0.0093 |
| 98 |
PELVIC CONGESTION |
1 |
0.0092 |
| 99 |
HUMAN CHORIONIC GONADOTROPIN DECREASED |
1 |
0.0090 |
| 100 |
HAEMORRHAGIC OVARIAN CYST |
5 |
0.0087 |
| 101 |
RENAL APLASIA |
6 |
0.0085 |
| 102 |
OVARIAN DISORDER |
8 |
0.0085 |
| 103 |
KIDNEY DUPLEX |
2 |
0.0083 |
| 104 |
HYDROURETER |
3 |
0.0079 |
| 105 |
CERVICAL INCOMPETENCE |
4 |
0.0079 |
| 106 |
INTRADUCTAL PAPILLOMA OF BREAST |
1 |
0.0078 |
| 107 |
OVARIAN CYST RUPTURED |
10 |
0.0078 |
| 108 |
ASCITES |
223 |
0.0076 |
| 109 |
CONGENITAL ANOMALY IN OFFSPRING |
1 |
0.0076 |
| 110 |
LABOUR INDUCTION |
1 |
0.0074 |
| 111 |
LIVER TENDERNESS |
2 |
0.0071 |
| 112 |
CRYPTORCHISM |
8 |
0.0071 |
| 113 |
HAEMORRHAGIC ASCITES |
2 |
0.0070 |
| 114 |
FALLOPIAN TUBE CANCER |
1 |
0.0069 |
| 115 |
PELIOSIS HEPATIS |
1 |
0.0069 |
| 116 |
GERM CELL CANCER |
1 |
0.0069 |
| 117 |
FALLOPIAN TUBE DISORDER |
2 |
0.0068 |
| 118 |
CHRONIC TONSILLITIS |
1 |
0.0065 |
| 119 |
KIDNEY CONGESTION |
1 |
0.0065 |
| 120 |
CAUDAL REGRESSION SYNDROME |
1 |
0.0064 |
| 121 |
FOETAL CARDIAC DISORDER |
2 |
0.0063 |
| 122 |
CHROMOSOMAL DELETION |
1 |
0.0063 |
| 123 |
MALIGNANT MELANOMA STAGE II |
1 |
0.0061 |
| 124 |
BENIGN HYDATIDIFORM MOLE |
2 |
0.0060 |
| 125 |
OVARIAN ADENOMA |
1 |
0.0060 |
| 126 |
ABORTION |
17 |
0.0058 |
| 127 |
BLOOD OESTROGEN DECREASED |
4 |
0.0057 |
| 128 |
BLOOD FOLLICLE STIMULATING HORMONE DECREASED |
1 |
0.0057 |
| 129 |
OVARIAN FAILURE |
3 |
0.0056 |
| 130 |
BLOOD LUTEINISING HORMONE DECREASED |
1 |
0.0056 |
| 131 |
ADMINISTRATION SITE DISCOMFORT |
1 |
0.0053 |
| 132 |
MOANING |
6 |
0.0053 |
| 133 |
COMPLICATION OF PREGNANCY |
4 |
0.0053 |
| 134 |
TRISOMY 18 |
2 |
0.0052 |
| 135 |
FOETAL HEART RATE DISORDER |
1 |
0.0052 |
| 136 |
HAEMORRHAGIC CYST |
2 |
0.0052 |
| 137 |
PREGNANCY TEST POSITIVE |
2 |
0.0051 |
| 138 |
HEART VALVE CALCIFICATION |
1 |
0.0050 |
| 139 |
PLACENTAL INSUFFICIENCY |
4 |
0.0050 |
| 140 |
RETINAL DEPOSITS |
1 |
0.0049 |
| 141 |
HYDROTHORAX |
4 |
0.0048 |
| 142 |
ANEMBRYONIC GESTATION |
1 |
0.0048 |
| 143 |
ABDOMINAL CAVITY DRAINAGE |
2 |
0.0047 |
| 144 |
BACTERIA URINE IDENTIFIED |
1 |
0.0047 |
| 145 |
BLOOD HUMAN CHORIONIC GONADOTROPIN INCREASED |
1 |
0.0047 |
| 146 |
FEMALE REPRODUCTIVE TRACT DISORDER |
1 |
0.0046 |
| 147 |
GLOSSOPTOSIS |
1 |
0.0046 |
| 148 |
JUGULAR VEIN THROMBOSIS |
8 |
0.0045 |
| 149 |
HEPATIC RUPTURE |
1 |
0.0045 |
| 150 |
CYST RUPTURE |
3 |
0.0044 |
| 151 |
INTRA-UTERINE DEATH |
7 |
0.0044 |
| 152 |
CHOLESTASIS OF PREGNANCY |
2 |
0.0043 |
| 153 |
CONTINUOUS POSITIVE AIRWAY PRESSURE |
1 |
0.0043 |
| 154 |
ANGINA BULLOSA HAEMORRHAGICA |
1 |
0.0043 |
| 155 |
PLACENTAL DISORDER |
4 |
0.0042 |
| 156 |
CONGENITAL HEART VALVE DISORDER |
1 |
0.0042 |
| 157 |
INTRA-ABDOMINAL HAEMORRHAGE |
10 |
0.0042 |
| 158 |
PULSE ABNORMAL |
10 |
0.0041 |
| 159 |
ABORTION THREATENED |
2 |
0.0040 |
| 160 |
MENINGORRHAGIA |
1 |
0.0040 |
| 161 |
ADNEXA UTERI PAIN |
5 |
0.0039 |
| 162 |
EPILEPTIC AURA |
1 |
0.0039 |
| 163 |
RUPTURED ECTOPIC PREGNANCY |
3 |
0.0039 |
| 164 |
FOETAL GROWTH RETARDATION |
3 |
0.0038 |
| 165 |
PLACENTA PRAEVIA |
3 |
0.0038 |
| 166 |
NEOVASCULARISATION |
1 |
0.0038 |
| 167 |
ANAL ATRESIA |
2 |
0.0037 |
| 168 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
25 |
0.0037 |
| 169 |
CYTOGENETIC ABNORMALITY |
4 |
0.0035 |
| 170 |
OESOPHAGEAL OEDEMA |
1 |
0.0035 |
| 171 |
SUBCLAVIAN VEIN THROMBOSIS |
4 |
0.0035 |
| 172 |
COMPLICATION OF DELIVERY |
1 |
0.0035 |
| 173 |
SHORTENED CERVIX |
1 |
0.0034 |
| 174 |
ADRENAL ADENOMA |
2 |
0.0034 |
| 175 |
GAMMA-GLUTAMYLTRANSFERASE ABNORMAL |
2 |
0.0033 |
| 176 |
TENSION |
20 |
0.0033 |
| 177 |
FOETAL HEART RATE ABNORMAL |
3 |
0.0032 |
| 178 |
DIAPHRAGMATIC HERNIA |
2 |
0.0032 |
| 179 |
PROGESTERONE DECREASED |
1 |
0.0032 |
| 180 |
ANOMALY OF EXTERNAL EAR CONGENITAL |
1 |
0.0032 |
| 181 |
PAPILLOMA |
1 |
0.0032 |
| 182 |
ARNOLD-CHIARI MALFORMATION |
3 |
0.0031 |
| 183 |
RED BLOOD CELL SCHISTOCYTES PRESENT |
1 |
0.0031 |
| 184 |
DEFECT CONDUCTION INTRAVENTRICULAR |
1 |
0.0031 |
| 185 |
ABORTION SPONTANEOUS |
123 |
0.0031 |
| 186 |
ALOPECIA TOTALIS |
1 |
0.0030 |
| 187 |
SMALL FOR DATES BABY |
15 |
0.0030 |
| 188 |
NEONATAL RESPIRATORY DEPRESSION |
1 |
0.0030 |
| 189 |
CRANIOPHARYNGIOMA |
1 |
0.0030 |
| 190 |
MENSTRUATION NORMAL |
1 |
0.0030 |
| 191 |
COAGULATION TIME SHORTENED |
1 |
0.0030 |
| 192 |
PREMENSTRUAL SYNDROME |
4 |
0.0029 |
| 193 |
NEONATAL INFECTION |
1 |
0.0029 |
| 194 |
HAEMORRHAGE IN PREGNANCY |
4 |
0.0028 |
| 195 |
PRODUCT COMPOUNDING QUALITY ISSUE |
1 |
0.0027 |
| 196 |
SINGLE UMBILICAL ARTERY |
1 |
0.0027 |
| 197 |
LOCAL REACTION |
2 |
0.0027 |
| 198 |
HYPOPROTEINAEMIA |
5 |
0.0026 |
| 199 |
ARTERIAL THROMBOSIS |
5 |
0.0026 |
| 200 |
BLOOD FOLLICLE STIMULATING HORMONE INCREASED |
1 |
0.0026 |
| 201 |
FACTOR V LEIDEN MUTATION |
1 |
0.0025 |
| 202 |
OVARIAN CYST |
25 |
0.0025 |
| 203 |
STILLBIRTH |
12 |
0.0025 |
| 204 |
ENDOMETRIAL HYPERPLASIA |
2 |
0.0025 |
| 205 |
BLOOD ELECTROLYTES ABNORMAL |
3 |
0.0024 |
| 206 |
DELUSIONAL PERCEPTION |
1 |
0.0024 |
| 207 |
CANDIDA TEST POSITIVE |
1 |
0.0024 |
| 208 |
HYPOCAPNIA |
1 |
0.0024 |
| 209 |
PYRAMIDAL TRACT SYNDROME |
1 |
0.0024 |
| 210 |
TRISOMY 21 |
3 |
0.0024 |
| 211 |
MELANOMA RECURRENT |
1 |
0.0024 |
| 212 |
AMAUROSIS |
2 |
0.0024 |
| 213 |
SUPERFICIAL VEIN THROMBOSIS |
2 |
0.0024 |
| 214 |
GENE MUTATION IDENTIFICATION TEST POSITIVE |
1 |
0.0024 |
| 215 |
APPARENT LIFE THREATENING EVENT |
1 |
0.0024 |
| 216 |
RETINAL PIGMENT EPITHELIOPATHY |
1 |
0.0023 |
| 217 |
OLIGURIA |
14 |
0.0023 |
| 218 |
OPERATIVE HAEMORRHAGE |
1 |
0.0022 |
| 219 |
CAESAREAN SECTION |
26 |
0.0022 |
| 220 |
ALLERGY TEST POSITIVE |
1 |
0.0022 |
| 221 |
URETERIC OBSTRUCTION |
3 |
0.0022 |
| 222 |
NECROSIS ISCHAEMIC |
1 |
0.0022 |
| 223 |
PELVIC INFECTION |
1 |
0.0022 |
| 224 |
MENINGIOMA BENIGN |
2 |
0.0022 |
| 225 |
THERAPEUTIC RESPONSE INCREASED |
2 |
0.0021 |
| 226 |
PYELOCALIECTASIS |
2 |
0.0021 |
| 227 |
COMA SCALE ABNORMAL |
6 |
0.0021 |
| 228 |
RESPIRATORY TRACT INFECTION BACTERIAL |
1 |
0.0020 |
| 229 |
THROMBOPHLEBITIS |
7 |
0.0020 |
| 230 |
CONGENITAL HYDROCEPHALUS |
1 |
0.0020 |
| 231 |
AUTISM |
2 |
0.0020 |
| 232 |
RIGHT ATRIAL DILATATION |
1 |
0.0020 |
| 233 |
PREMATURE LABOUR |
11 |
0.0019 |
| 234 |
SUBILEUS |
4 |
0.0019 |
| 235 |
ABDOMINAL INJURY |
1 |
0.0019 |
| 236 |
CARBOHYDRATE ANTIGEN 19-9 INCREASED |
1 |
0.0019 |
| 237 |
FOETAL MALFORMATION |
2 |
0.0018 |
| 238 |
HAEMORRHAGIC DISORDER |
2 |
0.0018 |
| 239 |
AMNIOTIC FLUID VOLUME DECREASED |
1 |
0.0018 |
| 240 |
HAEMORRHAGIC INFARCTION |
1 |
0.0018 |
| 241 |
ANENCEPHALY |
1 |
0.0018 |
| 242 |
CEREBRAL VENTRICLE DILATATION |
2 |
0.0017 |
| 243 |
TREATMENT DELAYED |
3 |
0.0017 |
| 244 |
RIGHT VENTRICULAR DILATATION |
1 |
0.0017 |
| 245 |
ISCHAEMIC CEREBRAL INFARCTION |
2 |
0.0017 |
| 246 |
DRUG EXPOSURE DURING PREGNANCY |
58 |
0.0017 |
| 247 |
PREGNANCY |
34 |
0.0017 |
| 248 |
MATERNAL DRUGS AFFECTING FOETUS |
13 |
0.0017 |
| 249 |
INDUCED LABOUR |
1 |
0.0017 |
| 250 |
ENDOMETRIOSIS |
8 |
0.0017 |
| 251 |
INTRA-ABDOMINAL FLUID COLLECTION |
3 |
0.0017 |
| 252 |
UTERINE POLYP |
3 |
0.0017 |
| 253 |
SACRAL PAIN |
1 |
0.0016 |
| 254 |
HYDROPS FOETALIS |
1 |
0.0016 |
| 255 |
PLEURAL DISORDER |
1 |
0.0016 |
| 256 |
BREECH PRESENTATION |
2 |
0.0016 |
| 257 |
SNORING |
6 |
0.0016 |
| 258 |
ENDOMETRIAL ADENOCARCINOMA |
1 |
0.0016 |
| 259 |
DRUG LEVEL DECREASED |
16 |
0.0016 |
| 260 |
GESTATIONAL HYPERTENSION |
2 |
0.0015 |
| 261 |
FOETAL DEATH |
8 |
0.0015 |
| 262 |
EXPOSURE VIA FATHER |
2 |
0.0015 |
| 263 |
SCLERAL DISCOLOURATION |
1 |
0.0015 |
| 264 |
ENDOMETRITIS |
1 |
0.0015 |
| 265 |
COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS |
1 |
0.0015 |
| 266 |
EFFUSION |
2 |
0.0015 |
| 267 |
SPINA BIFIDA |
3 |
0.0014 |
| 268 |
LEIOMYOMA |
1 |
0.0014 |
| 269 |
DYSLALIA |
1 |
0.0014 |
| 270 |
BLOOD BILIRUBIN UNCONJUGATED INCREASED |
1 |
0.0014 |
| 271 |
ASTHMATIC CRISIS |
5 |
0.0014 |
| 272 |
HEMIANOPIA HOMONYMOUS |
1 |
0.0014 |
| 273 |
PELVIC INFLAMMATORY DISEASE |
2 |
0.0013 |
| 274 |
CHLAMYDIAL INFECTION |
1 |
0.0013 |
| 275 |
QRS AXIS ABNORMAL |
1 |
0.0013 |
| 276 |
POLYCYSTIC OVARIES |
2 |
0.0013 |
| 277 |
BREAST FEEDING |
1 |
0.0013 |
| 278 |
CROUP INFECTIOUS |
1 |
0.0013 |
| 279 |
PULSE ABSENT |
6 |
0.0013 |
| 280 |
HAEMOPERITONEUM |
1 |
0.0012 |
| 281 |
PLEURAL EFFUSION |
76 |
0.0012 |
| 282 |
PREMATURE RUPTURE OF MEMBRANES |
3 |
0.0012 |
| 283 |
LEUKOCYTURIA |
1 |
0.0012 |
| 284 |
OLIGOHYDRAMNIOS |
4 |
0.0012 |
| 285 |
COVID-19 IMMUNISATION |
1 |
0.0012 |
| 286 |
CONGENITAL CYSTIC KIDNEY DISEASE |
1 |
0.0012 |
| 287 |
UTERINE HAEMORRHAGE |
5 |
0.0012 |
| 288 |
LIP PRURITUS |
1 |
0.0012 |
| 289 |
PATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0012 |
| 290 |
HYPOPITUITARISM |
2 |
0.0011 |
| 291 |
ABDOMINAL DISTENSION |
120 |
0.0011 |
| 292 |
ABDOMINAL PAIN LOWER |
29 |
0.0011 |
| 293 |
HYPERLEUKOCYTOSIS |
1 |
0.0011 |
| 294 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
80 |
0.0011 |
| 295 |
CEREBRAL VENOUS THROMBOSIS |
2 |
0.0011 |
| 296 |
LIGAMENT DISORDER |
1 |
0.0011 |
| 297 |
SUSPECTED PRODUCT QUALITY ISSUE |
2 |
0.0011 |
| 298 |
ADVERSE FOOD REACTION |
1 |
0.0011 |
| 299 |
CEREBRAL THROMBOSIS |
3 |
0.0011 |
| 300 |
HEPATIC CONGESTION |
1 |
0.0011 |
| 301 |
CROSS SENSITIVITY REACTION |
1 |
0.0010 |
| 302 |
HAEMOPHILUS INFECTION |
1 |
0.0010 |
| 303 |
HYPOFIBRINOGENAEMIA |
1 |
0.0010 |
| 304 |
ABDOMINAL TENDERNESS |
5 |
0.0010 |
| 305 |
LOW BIRTH WEIGHT BABY |
8 |
0.0010 |
| 306 |
SEMEN VOLUME DECREASED |
1 |
0.0010 |
| 307 |
SUDDEN HEARING LOSS |
2 |
0.0010 |
| 308 |
BENIGN BREAST NEOPLASM |
1 |
0.0010 |
| 309 |
INTRACARDIAC THROMBUS |
3 |
0.0010 |
| 310 |
CYTOGENETIC ANALYSIS ABNORMAL |
1 |
0.0010 |
| 311 |
ORTHOPNOEA |
3 |
0.0009 |
| 312 |
PELVIC PAIN |
17 |
0.0009 |
| 313 |
INTRACRANIAL VENOUS SINUS THROMBOSIS |
1 |
0.0009 |
| 314 |
CEREBRAL ARTERY OCCLUSION |
1 |
0.0009 |
| 315 |
ORCHITIS |
1 |
0.0009 |
| 316 |
NORMAL NEWBORN |
5 |
0.0009 |
| 317 |
DRUG EXPOSURE VIA BREAST MILK |
1 |
0.0009 |
| 318 |
IMMEDIATE POST-INJECTION REACTION |
1 |
0.0009 |
| 319 |
RIGHT VENTRICULAR DYSFUNCTION |
1 |
0.0009 |
| 320 |
GENERALISED TONIC-CLONIC SEIZURE |
15 |
0.0009 |
| 321 |
OESTROGEN RECEPTOR ASSAY POSITIVE |
1 |
0.0009 |
| 322 |
LIGAMENT INJURY |
1 |
0.0009 |
| 323 |
DIFFUSE ALVEOLAR DAMAGE |
1 |
0.0009 |
| 324 |
UTERINE DISORDER |
2 |
0.0009 |
| 325 |
ERYTHEMA NODOSUM |
3 |
0.0009 |
| 326 |
SENSE OF OPPRESSION |
1 |
0.0008 |
| 327 |
PULMONARY INFARCTION |
2 |
0.0008 |
| 328 |
CEREBRAL ARTERY EMBOLISM |
1 |
0.0008 |
| 329 |
HAEMATOCRIT ABNORMAL |
1 |
0.0008 |
| 330 |
PERSECUTORY DELUSION |
2 |
0.0008 |
| 331 |
PREMATURE BABY |
24 |
0.0008 |
| 332 |
DISSEMINATED TUBERCULOSIS |
2 |
0.0008 |
| 333 |
HEPATOSPLENOMEGALY |
2 |
0.0008 |
| 334 |
VENOUS THROMBOSIS |
3 |
0.0008 |
| 335 |
FEELING GUILTY |
1 |
0.0008 |
| 336 |
ANGIONEUROTIC OEDEMA |
2 |
0.0007 |
| 337 |
HYDROCEPHALUS |
4 |
0.0007 |
| 338 |
DEMYELINATION |
3 |
0.0007 |
| 339 |
MENINGITIS VIRAL |
1 |
0.0007 |
| 340 |
DEATH NEONATAL |
1 |
0.0007 |
| 341 |
LIVE BIRTH |
6 |
0.0007 |
| 342 |
LUNG CONSOLIDATION |
2 |
0.0007 |
| 343 |
ANTICONVULSANT DRUG LEVEL DECREASED |
1 |
0.0007 |
| 344 |
PRECANCEROUS CELLS PRESENT |
1 |
0.0007 |
| 345 |
PELVIC VENOUS THROMBOSIS |
1 |
0.0007 |
| 346 |
MULTIPLE CONGENITAL ABNORMALITIES |
1 |
0.0007 |
| 347 |
HAEMOTHORAX |
2 |
0.0007 |
| 348 |
UTERINE LEIOMYOMA |
5 |
0.0007 |
| 349 |
HYPERTRIGLYCERIDAEMIA |
4 |
0.0007 |
| 350 |
BRAIN HERNIATION |
2 |
0.0007 |
| 351 |
INFERTILITY |
1 |
0.0007 |
| 352 |
ADHESION |
1 |
0.0007 |
| 353 |
LIP DRY |
6 |
0.0007 |
| 354 |
HAEMOGLOBIN INCREASED |
3 |
0.0007 |
| 355 |
PREMATURE SEPARATION OF PLACENTA |
1 |
0.0006 |
| 356 |
LOCALISED OEDEMA |
3 |
0.0006 |
| 357 |
TALIPES |
2 |
0.0006 |
| 358 |
INFERTILITY FEMALE |
1 |
0.0006 |
| 359 |
APNOEA |
5 |
0.0006 |
| 360 |
PHARYNGEAL PARAESTHESIA |
1 |
0.0006 |
| 361 |
GESTATIONAL DIABETES |
3 |
0.0006 |
| 362 |
HORMONE LEVEL ABNORMAL |
3 |
0.0006 |
| 363 |
RENAL CELL CARCINOMA |
3 |
0.0006 |
| 364 |
INJECTION RELATED REACTION |
1 |
0.0006 |
| 365 |
MATERNAL EXPOSURE DURING PREGNANCY |
54 |
0.0006 |
| 366 |
GASTRIC DILATATION |
1 |
0.0006 |
| 367 |
GAZE PALSY |
1 |
0.0006 |
| 368 |
BLOOD AMYLASE INCREASED |
1 |
0.0006 |
| 369 |
PERIORBITAL OEDEMA |
3 |
0.0006 |
| 370 |
LACK OF INJECTION SITE ROTATION |
1 |
0.0006 |
| 371 |
ALOPECIA AREATA |
1 |
0.0006 |
| 372 |
EMBOLIC STROKE |
2 |
0.0006 |
| 373 |
FIBRIN D DIMER INCREASED |
2 |
0.0006 |
| 374 |
ABDOMINAL PAIN |
130 |
0.0006 |
| 375 |
PUPILLARY REFLEX IMPAIRED |
1 |
0.0005 |
| 376 |
INTRACRANIAL PRESSURE INCREASED |
3 |
0.0005 |
| 377 |
RETINOPATHY |
2 |
0.0005 |
| 378 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
2 |
0.0005 |
| 379 |
IMPATIENCE |
1 |
0.0005 |
| 380 |
ABORTION INDUCED |
5 |
0.0005 |
| 381 |
VAGINAL HAEMORRHAGE |
23 |
0.0005 |
| 382 |
MECHANICAL VENTILATION |
1 |
0.0005 |
| 383 |
HYPERCOAGULATION |
1 |
0.0005 |
| 384 |
RETINAL OEDEMA |
1 |
0.0005 |
| 385 |
MOTION SICKNESS |
1 |
0.0005 |
| 386 |
HYPERVENTILATION |
3 |
0.0005 |
| 387 |
POST PROCEDURAL HAEMORRHAGE |
6 |
0.0005 |
| 388 |
CUTANEOUS LUPUS ERYTHEMATOSUS |
1 |
0.0005 |
| 389 |
HYPOVOLAEMIA |
3 |
0.0005 |
| 390 |
EMPYEMA |
1 |
0.0005 |
| 391 |
PREMATURE DELIVERY |
8 |
0.0005 |
| 392 |
ARTERIOSPASM CORONARY |
2 |
0.0005 |
| 393 |
HEPATOCELLULAR INJURY |
7 |
0.0005 |
| 394 |
FOETAL GROWTH RESTRICTION |
3 |
0.0005 |
| 395 |
NIPPLE PAIN |
1 |
0.0005 |
| 396 |
CAPILLARY LEAK SYNDROME |
1 |
0.0005 |
| 397 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
1 |
0.0005 |
| 398 |
THYROID FUNCTION TEST ABNORMAL |
2 |
0.0005 |
| 399 |
FOETAL DISTRESS SYNDROME |
1 |
0.0005 |
| 400 |
BREAST PAIN |
5 |
0.0005 |
| 401 |
AMYOTROPHIC LATERAL SCLEROSIS |
1 |
0.0005 |
| 402 |
JAW FRACTURE |
1 |
0.0005 |
| 403 |
FACIAL PALSY |
1 |
0.0005 |
| 404 |
CERVICAL DYSPLASIA |
1 |
0.0005 |
| 405 |
CEREBELLAR SYNDROME |
1 |
0.0005 |
| 406 |
ENDOMETRIAL CANCER |
1 |
0.0005 |
| 407 |
ADVERSE REACTION |
6 |
0.0005 |
| 408 |
IDIOPATHIC INTRACRANIAL HYPERTENSION |
1 |
0.0004 |
| 409 |
SUSPECTED OFF LABEL USE |
2 |
0.0004 |
| 410 |
OPTIC NEURITIS |
4 |
0.0004 |
| 411 |
PERIARTHRITIS |
1 |
0.0004 |
| 412 |
OVARIAN CANCER |
4 |
0.0004 |
| 413 |
CARDIOVASCULAR DISORDER |
11 |
0.0004 |
| 414 |
HYPERTRANSAMINASAEMIA |
3 |
0.0004 |
| 415 |
FEAR OF INJECTION |
3 |
0.0004 |
| 416 |
GASTROINTESTINAL TOXICITY |
2 |
0.0004 |
| 417 |
GUILLAIN-BARRE SYNDROME |
2 |
0.0004 |
| 418 |
DENTAL OPERATION |
1 |
0.0004 |
| 419 |
INFLAMMATORY MARKER INCREASED |
2 |
0.0004 |
| 420 |
HYDRONEPHROSIS |
3 |
0.0004 |
| 421 |
ABNORMAL UTERINE BLEEDING |
1 |
0.0004 |
| 422 |
BLOOD CHLORIDE DECREASED |
1 |
0.0004 |
| 423 |
UNRESPONSIVE TO STIMULI |
10 |
0.0004 |
| 424 |
LEUKOCYTOSIS |
7 |
0.0004 |
| 425 |
COMPARTMENT SYNDROME |
1 |
0.0004 |
| 426 |
AREFLEXIA |
1 |
0.0004 |
| 427 |
GASTROINTESTINAL MOTILITY DISORDER |
2 |
0.0004 |
| 428 |
ABDOMINAL MASS |
1 |
0.0004 |
| 429 |
HYPONATRAEMIA |
21 |
0.0004 |
| 430 |
RHINITIS |
3 |
0.0004 |
| 431 |
BREAST SWELLING |
1 |
0.0004 |
| 432 |
LARYNGOSPASM |
1 |
0.0004 |
| 433 |
EXPOSURE DURING PREGNANCY |
23 |
0.0004 |
| 434 |
INVASIVE DUCTAL BREAST CARCINOMA |
1 |
0.0004 |
| 435 |
ESCHERICHIA INFECTION |
3 |
0.0004 |
| 436 |
DEAFNESS UNILATERAL |
2 |
0.0004 |
| 437 |
PLEURITIC PAIN |
1 |
0.0004 |
| 438 |
HEMIPLEGIA |
3 |
0.0004 |
| 439 |
ANAL HAEMORRHAGE |
1 |
0.0004 |
| 440 |
PSYCHOMOTOR RETARDATION |
1 |
0.0004 |
| 441 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
1 |
0.0004 |
| 442 |
HAEMATOCRIT DECREASED |
7 |
0.0004 |
| 443 |
VENTRICULAR SEPTAL DEFECT |
2 |
0.0003 |
| 444 |
LUNG CANCER METASTATIC |
1 |
0.0003 |
| 445 |
URINE OUTPUT DECREASED |
3 |
0.0003 |
| 446 |
PULMONARY PAIN |
1 |
0.0003 |
| 447 |
BLOOD CULTURE POSITIVE |
1 |
0.0003 |
| 448 |
FOETAL EXPOSURE DURING PREGNANCY |
27 |
0.0003 |
| 449 |
TYPE 1 DIABETES MELLITUS |
2 |
0.0003 |
| 450 |
CHEST DISCOMFORT |
34 |
0.0003 |
| 451 |
CHEST X-RAY ABNORMAL |
1 |
0.0003 |
| 452 |
BRAIN DEATH |
1 |
0.0003 |
| 453 |
BLOOD CREATININE DECREASED |
1 |
0.0003 |
| 454 |
TRANSAMINASES INCREASED |
7 |
0.0003 |
| 455 |
PANCREATITIS ACUTE |
7 |
0.0003 |
| 456 |
NEEDLE ISSUE |
9 |
0.0003 |
| 457 |
ANTINUCLEAR ANTIBODY POSITIVE |
1 |
0.0003 |
| 458 |
BREAST ENLARGEMENT |
1 |
0.0003 |
| 459 |
OTITIS MEDIA |
1 |
0.0003 |
| 460 |
CYTOLYTIC HEPATITIS |
1 |
0.0003 |
| 461 |
HYPOTONIA |
3 |
0.0003 |
| 462 |
VAGINAL DISCHARGE |
3 |
0.0003 |
| 463 |
NEOPLASM RECURRENCE |
1 |
0.0003 |
| 464 |
TACHYPNOEA |
4 |
0.0003 |
| 465 |
PALLOR |
8 |
0.0003 |
| 466 |
MOOD ALTERED |
8 |
0.0003 |
| 467 |
NEPHROTIC SYNDROME |
2 |
0.0003 |
| 468 |
POLYMENORRHOEA |
1 |
0.0003 |
| 469 |
CEREBRAL INFARCTION |
7 |
0.0003 |
| 470 |
MASS |
4 |
0.0003 |
| 471 |
INJECTION SITE DISCOMFORT |
3 |
0.0003 |
| 472 |
BRONCHIOLITIS |
1 |
0.0003 |
| 473 |
FACIAL PARESIS |
1 |
0.0003 |
| 474 |
LUNG TRANSPLANT |
1 |
0.0003 |
| 475 |
HAEMORRHAGIC DIATHESIS |
1 |
0.0003 |
| 476 |
ISCHAEMIC STROKE |
5 |
0.0003 |
| 477 |
SYNCOPE |
28 |
0.0003 |
| 478 |
FRUSTRATION |
1 |
0.0003 |
| 479 |
DECREASED ACTIVITY |
3 |
0.0003 |
| 480 |
CAROTID ARTERY OCCLUSION |
1 |
0.0003 |
| 481 |
HYPOMANIA |
1 |
0.0003 |
| 482 |
ANAPHYLACTIC REACTION |
15 |
0.0003 |
| 483 |
FEELING DRUNK |
2 |
0.0003 |
| 484 |
PULMONARY MASS |
4 |
0.0003 |
| 485 |
CHRONIC SINUSITIS |
1 |
0.0003 |
| 486 |
GASTRITIS |
7 |
0.0003 |
| 487 |
PROTEIN TOTAL DECREASED |
1 |
0.0003 |
| 488 |
BREAST TENDERNESS |
2 |
0.0003 |
| 489 |
AUTOIMMUNE THYROIDITIS |
1 |
0.0003 |
| 490 |
PRODUCT STORAGE ISSUE |
1 |
0.0003 |
| 491 |
PANIC DISORDER |
1 |
0.0003 |
| 492 |
HYPOALBUMINAEMIA |
2 |
0.0003 |
| 493 |
CARDIOPULMONARY FAILURE |
1 |
0.0003 |
| 494 |
MULTIPLE ALLERGIES |
2 |
0.0003 |
| 495 |
PATENT DUCTUS ARTERIOSUS |
1 |
0.0003 |
| 496 |
ENURESIS |
1 |
0.0002 |
| 497 |
BURSITIS |
3 |
0.0002 |
| 498 |
HOMICIDAL IDEATION |
1 |
0.0002 |
| 499 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
1 |
0.0002 |
| 500 |
BODY TEMPERATURE INCREASED |
5 |
0.0002 |
| 501 |
PERIPHERAL ISCHAEMIA |
1 |
0.0002 |
| 502 |
ANAPHYLACTOID REACTION |
1 |
0.0002 |
| 503 |
EMBOLISM |
2 |
0.0002 |
| 504 |
DYSPNOEA EXERTIONAL |
9 |
0.0002 |
| 505 |
FACE OEDEMA |
4 |
0.0002 |
| 506 |
HYPERPYREXIA |
1 |
0.0002 |
| 507 |
RETCHING |
5 |
0.0002 |
| 508 |
MYDRIASIS |
3 |
0.0002 |
| 509 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
4 |
0.0002 |
| 510 |
SKIN HYPERPIGMENTATION |
2 |
0.0002 |
| 511 |
PLATELET COUNT INCREASED |
3 |
0.0002 |
| 512 |
GINGIVAL SWELLING |
1 |
0.0002 |
| 513 |
LIGAMENT RUPTURE |
1 |
0.0002 |
| 514 |
DYSMENORRHOEA |
3 |
0.0002 |
| 515 |
TACHYCARDIA |
20 |
0.0002 |
| 516 |
EYE HAEMORRHAGE |
3 |
0.0002 |
| 517 |
MENINGITIS ASEPTIC |
1 |
0.0002 |
| 518 |
THERAPY NON-RESPONDER |
10 |
0.0002 |
| 519 |
PAPILLOEDEMA |
1 |
0.0002 |
| 520 |
PULMONARY EMBOLISM |
21 |
0.0002 |
| 521 |
LOSS OF CONSCIOUSNESS |
28 |
0.0002 |
| 522 |
BLOOD PRESSURE DIASTOLIC INCREASED |
1 |
0.0002 |
| 523 |
PERFORMANCE STATUS DECREASED |
1 |
0.0002 |
| 524 |
APPENDICITIS |
2 |
0.0002 |
| 525 |
BLOOD SODIUM DECREASED |
4 |
0.0002 |
| 526 |
BLOOD PROLACTIN INCREASED |
1 |
0.0002 |
| 527 |
SARCOIDOSIS |
1 |
0.0002 |
| 528 |
PRODUCT PACKAGING ISSUE |
2 |
0.0002 |
| 529 |
WHITE BLOOD CELL COUNT INCREASED |
8 |
0.0002 |
| 530 |
CHOLESTASIS |
4 |
0.0002 |
| 531 |
AFFECT LABILITY |
2 |
0.0002 |
| 532 |
INJECTION SITE HAEMATOMA |
3 |
0.0002 |
| 533 |
PRESYNCOPE |
5 |
0.0002 |
| 534 |
MENORRHAGIA |
4 |
0.0002 |
| 535 |
HEPATOMEGALY |
2 |
0.0002 |
| 536 |
BREATH SOUNDS ABNORMAL |
1 |
0.0002 |
| 537 |
EXPIRED DRUG ADMINISTERED |
1 |
0.0002 |
| 538 |
ANEURYSM |
1 |
0.0002 |
| 539 |
PROTEIN URINE PRESENT |
1 |
0.0002 |
| 540 |
HYPERKALAEMIA |
7 |
0.0002 |
| 541 |
INJURY ASSOCIATED WITH DEVICE |
4 |
0.0002 |
| 542 |
PETIT MAL EPILEPSY |
1 |
0.0002 |
| 543 |
ALANINE AMINOTRANSFERASE INCREASED |
12 |
0.0002 |
| 544 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
1 |
0.0002 |
| 545 |
CEREBRAL ISCHAEMIA |
1 |
0.0002 |
| 546 |
MUSCULOSKELETAL CHEST PAIN |
3 |
0.0002 |
| 547 |
VENTRICULAR EXTRASYSTOLES |
2 |
0.0002 |
| 548 |
CATATONIA |
1 |
0.0002 |
| 549 |
DYSURIA |
7 |
0.0002 |
| 550 |
POLYARTHRITIS |
1 |
0.0002 |
| 551 |
HALLUCINATION, VISUAL |
4 |
0.0002 |
| 552 |
SUDDEN DEATH |
2 |
0.0002 |
| 553 |
HALLUCINATION, AUDITORY |
3 |
0.0002 |
| 554 |
BREAST CANCER FEMALE |
5 |
0.0002 |
| 555 |
IMPAIRED WORK ABILITY |
4 |
0.0002 |
| 556 |
FOOD POISONING |
1 |
0.0002 |
| 557 |
INJECTION SITE DISCHARGE |
1 |
0.0002 |
| 558 |
OEDEMA |
10 |
0.0002 |
| 559 |
GASTROINTESTINAL PAIN |
2 |
0.0002 |
| 560 |
THERAPEUTIC RESPONSE DECREASED |
11 |
0.0002 |
| 561 |
VOMITING |
85 |
0.0002 |
| 562 |
PROCEDURAL PAIN |
5 |
0.0002 |
| 563 |
PALPITATIONS |
21 |
0.0002 |
| 564 |
DYSPNOEA |
100 |
0.0002 |
| 565 |
INJECTION SITE BRUISING |
14 |
0.0002 |
| 566 |
NEUROLOGICAL SYMPTOM |
1 |
0.0002 |
| 567 |
HYPERTONIA |
1 |
0.0002 |
| 568 |
EYELID OEDEMA |
2 |
0.0002 |
| 569 |
ASPARTATE AMINOTRANSFERASE INCREASED |
9 |
0.0002 |
| 570 |
CHOLECYSTITIS |
2 |
0.0002 |
| 571 |
PROTHROMBIN TIME PROLONGED |
1 |
0.0002 |
| 572 |
EPILEPSY |
5 |
0.0002 |
| 573 |
MENISCUS INJURY |
1 |
0.0002 |
| 574 |
CYST |
2 |
0.0002 |
| 575 |
BACTERIAL INFECTION |
3 |
0.0002 |
| 576 |
INFUSION SITE SWELLING |
1 |
0.0002 |
| 577 |
BRAIN OEDEMA |
2 |
0.0002 |
| 578 |
INJECTION SITE IRRITATION |
2 |
0.0002 |
| 579 |
SCREAMING |
1 |
0.0002 |
| 580 |
HEPATIC CYTOLYSIS |
2 |
0.0002 |
| 581 |
PROCTALGIA |
1 |
0.0002 |
| 582 |
ABDOMINAL DISCOMFORT |
26 |
0.0002 |
| 583 |
POOR QUALITY DRUG ADMINISTERED |
1 |
0.0002 |
| 584 |
INCOHERENT |
1 |
0.0002 |
| 585 |
INJECTION SITE INDURATION |
2 |
0.0002 |
| 586 |
DEEP VEIN THROMBOSIS |
10 |
0.0002 |
| 587 |
PRODUCT PREPARATION ISSUE |
1 |
0.0002 |
| 588 |
DYSGRAPHIA |
1 |
0.0002 |
| 589 |
IMMUNE SYSTEM DISORDER |
2 |
0.0002 |
| 590 |
PRODUCT FORMULATION ISSUE |
1 |
0.0002 |
| 591 |
MALIGNANT MELANOMA |
2 |
0.0001 |
| 592 |
EYE MOVEMENT DISORDER |
1 |
0.0001 |
| 593 |
RESPIRATORY ARREST |
4 |
0.0001 |
| 594 |
RESPIRATION ABNORMAL |
1 |
0.0001 |
| 595 |
HAIR GROWTH ABNORMAL |
1 |
0.0001 |
| 596 |
FORMICATION |
1 |
0.0001 |
| 597 |
HUNGER |
2 |
0.0001 |
| 598 |
EATING DISORDER |
3 |
0.0001 |
| 599 |
PARALYSIS |
2 |
0.0001 |
| 600 |
PARAESTHESIA ORAL |
2 |
0.0001 |
| 601 |
PULMONARY ARTERIAL HYPERTENSION |
2 |
0.0001 |
| 602 |
GASTROENTERITIS |
2 |
0.0001 |
| 603 |
ACUTE MYOCARDIAL INFARCTION |
4 |
0.0001 |
| 604 |
LABORATORY TEST ABNORMAL |
4 |
0.0001 |
| 605 |
BLOOD PRESSURE DIASTOLIC DECREASED |
1 |
0.0001 |
| 606 |
HEPATOTOXICITY |
3 |
0.0001 |
| 607 |
HEPATIC FUNCTION ABNORMAL |
5 |
0.0001 |
| 608 |
RESPIRATORY DISORDER |
4 |
0.0001 |
| 609 |
HOT FLUSH |
10 |
0.0001 |
| 610 |
DRUG INTERACTION |
21 |
0.0001 |
| 611 |
NAUSEA |
104 |
0.0001 |
| 612 |
DISCOMFORT |
8 |
0.0001 |
| 613 |
PERICARDIAL EFFUSION |
3 |
0.0001 |
| 614 |
CONGENITAL ANOMALY |
1 |
0.0001 |
| 615 |
CONCUSSION |
1 |
0.0001 |
| 616 |
APHTHOUS ULCER |
1 |
0.0001 |
| 617 |
ACUTE MYELOID LEUKAEMIA |
2 |
0.0001 |
| 618 |
MENINGIOMA |
2 |
0.0001 |
| 619 |
ELECTROCARDIOGRAM ABNORMAL |
1 |
0.0001 |
| 620 |
AFFECTIVE DISORDER |
1 |
0.0001 |
| 621 |
PNEUMOTHORAX |
2 |
0.0001 |
| 622 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 623 |
MOOD SWINGS |
4 |
0.0001 |
| 624 |
ABSCESS |
2 |
0.0001 |
| 625 |
HAEMORRHAGE |
13 |
0.0001 |
| 626 |
SENSORY LOSS |
1 |
0.0001 |
| 627 |
UNDERDOSE |
9 |
0.0001 |
| 628 |
LIVER INJURY |
3 |
0.0001 |
| 629 |
POLYURIA |
1 |
0.0001 |
| 630 |
ABNORMAL FAECES |
1 |
0.0001 |
| 631 |
VENTRICULAR TACHYCARDIA |
2 |
0.0001 |
| 632 |
PRODUCT USE IN UNAPPROVED INDICATION |
30 |
0.0001 |
| 633 |
INJECTION SITE ERYTHEMA |
15 |
0.0001 |
| 634 |
DRUG LEVEL INCREASED |
2 |
0.0001 |
| 635 |
ACUTE CORONARY SYNDROME |
1 |
0.0001 |
| 636 |
PSYCHOMOTOR HYPERACTIVITY |
2 |
0.0001 |
| 637 |
BREAST CANCER STAGE II |
1 |
0.0001 |
| 638 |
COAGULOPATHY |
2 |
0.0001 |
| 639 |
URINARY RETENTION |
4 |
0.0001 |
| 640 |
CIRCULATORY COLLAPSE |
2 |
0.0001 |
| 641 |
HAEMATURIA |
4 |
0.0001 |
| 642 |
MULTIPLE SCLEROSIS RELAPSE |
8 |
0.0001 |
| 643 |
PRODUCT CONTAINER ISSUE |
1 |
0.0001 |
| 644 |
ANAPHYLACTIC SHOCK |
3 |
0.0001 |
| 645 |
ANURIA |
1 |
0.0001 |
| 646 |
HAEMATOMA |
3 |
0.0001 |
| 647 |
PYELONEPHRITIS |
1 |
0.0001 |
| 648 |
DELIRIUM |
4 |
0.0001 |
| 649 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
1 |
0.0001 |
| 650 |
AMENORRHOEA |
2 |
0.0001 |
| 651 |
BLOOD TRIGLYCERIDES INCREASED |
2 |
0.0001 |
| 652 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
2 |
0.0001 |
| 653 |
HAEMOLYTIC ANAEMIA |
1 |
0.0001 |
| 654 |
HEAVY MENSTRUAL BLEEDING |
1 |
0.0001 |
| 655 |
BLOOD BILIRUBIN INCREASED |
3 |
0.0001 |
| 656 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 657 |
CRYING |
4 |
0.0001 |
| 658 |
C-REACTIVE PROTEIN INCREASED |
4 |
0.0001 |
| 659 |
BRAIN NEOPLASM |
1 |
0.0001 |
| 660 |
RESPIRATORY DISTRESS |
3 |
0.0001 |
| 661 |
GRAND MAL CONVULSION |
1 |
0.0001 |
| 662 |
THINKING ABNORMAL |
2 |
0.0001 |
| 663 |
BREAST CANCER |
10 |
0.0001 |
| 664 |
ERYTHEMA MULTIFORME |
1 |
0.0001 |
| 665 |
HEPATIC ENCEPHALOPATHY |
1 |
0.0001 |
| 666 |
HAEMOGLOBIN DECREASED |
11 |
0.0001 |
| 667 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
3 |
0.0001 |
| 668 |
RECALLED PRODUCT ADMINISTERED |
1 |
0.0001 |
| 669 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
1 |
0.0001 |
| 670 |
MULTIPLE SCLEROSIS |
5 |
0.0001 |
| 671 |
INJECTION SITE PRURITUS |
7 |
0.0001 |
| 672 |
POST PROCEDURAL COMPLICATION |
2 |
0.0001 |
| 673 |
ATELECTASIS |
1 |
0.0001 |
| 674 |
LIVER FUNCTION TEST ABNORMAL |
3 |
0.0001 |
| 675 |
EAR PAIN |
2 |
0.0001 |
| 676 |
CHOKING |
2 |
0.0001 |
| 677 |
INJECTION SITE REACTION |
7 |
0.0001 |
| 678 |
PARAESTHESIA |
16 |
0.0001 |
| 679 |
BODY TEMPERATURE DECREASED |
1 |
0.0001 |
| 680 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 681 |
MALAISE |
44 |
0.0001 |
| 682 |
INJECTION SITE HAEMORRHAGE |
8 |
0.0001 |
| 683 |
APHASIA |
3 |
0.0001 |
| 684 |
HYPOTHERMIA |
1 |
0.0001 |
| 685 |
TASTE DISORDER |
2 |
0.0001 |
| 686 |
DRY THROAT |
1 |
0.0001 |
| 687 |
FLUID RETENTION |
5 |
0.0001 |
| 688 |
INJECTION SITE RASH |
3 |
0.0001 |
| 689 |
EAR DISCOMFORT |
1 |
0.0001 |
| 690 |
EMOTIONAL DISORDER |
3 |
0.0001 |
| 691 |
GYNAECOMASTIA |
3 |
0.0001 |
| 692 |
LIMB DISCOMFORT |
3 |
0.0001 |
| 693 |
CARDIAC ARREST |
8 |
0.0001 |
| 694 |
HYPERBILIRUBINAEMIA |
1 |
0.0001 |
| 695 |
SPEECH DISORDER |
5 |
0.0001 |
| 696 |
SEIZURE |
11 |
0.0001 |
| 697 |
PANCREATITIS |
5 |
0.0001 |
| 698 |
DEPRESSED MOOD |
5 |
0.0001 |
| 699 |
RENAL PAIN |
1 |
0.0001 |
| 700 |
RENAL FAILURE ACUTE |
4 |
0.0001 |
| 701 |
POOR QUALITY SLEEP |
2 |
0.0001 |
| 702 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
2 |
0.0001 |
| 703 |
VIRAL INFECTION |
3 |
0.0001 |
| 704 |
LIP SWELLING |
3 |
0.0001 |
| 705 |
HYPERTENSIVE CRISIS |
1 |
0.0001 |
| 706 |
MALNUTRITION |
1 |
0.0001 |
| 707 |
HEPATIC ENZYME INCREASED |
6 |
0.0001 |
| 708 |
INTERNAL HAEMORRHAGE |
1 |
0.0001 |
| 709 |
MYOCARDITIS |
1 |
0.0001 |
| 710 |
SHOCK |
2 |
0.0001 |
| 711 |
METASTASES TO LUNG |
1 |
0.0001 |
| 712 |
MADAROSIS |
1 |
0.0001 |
| 713 |
OFF LABEL USE |
75 |
0.0001 |
| 714 |
DEVICE MALFUNCTION |
6 |
0.0001 |
| 715 |
HEADACHE |
53 |
0.0001 |
| 716 |
TREATMENT FAILURE |
7 |
0.0001 |
| 717 |
ARRHYTHMIA |
4 |
0.0001 |
| 718 |
SOMNOLENCE |
17 |
0.0001 |
| 719 |
NEUROLEPTIC MALIGNANT SYNDROME |
1 |
0.0001 |
| 720 |
MIGRAINE |
8 |
0.0001 |
| 721 |
MUSCLE RIGIDITY |
1 |
0.0001 |
| 722 |
NEURALGIA |
2 |
0.0001 |
| 723 |
RESTLESSNESS |
3 |
0.0001 |
| 724 |
MUSCLE SPASTICITY |
1 |
0.0001 |
| 725 |
INJECTION SITE EXTRAVASATION |
1 |
0.0001 |
| 726 |
HYPERCALCAEMIA |
1 |
0.0001 |
| 727 |
ABNORMAL WEIGHT GAIN |
1 |
0.0001 |
| 728 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 729 |
WEIGHT INCREASED |
18 |
0.0001 |
| 730 |
HAIR COLOUR CHANGES |
1 |
0.0001 |
| 731 |
INJECTION SITE SWELLING |
6 |
0.0001 |
| 732 |
HYPOPHAGIA |
2 |
0.0001 |
| 733 |
HEPATITIS |
2 |
0.0001 |
| 734 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
1 |
0.0001 |
| 735 |
RASH GENERALISED |
2 |
0.0001 |
| 736 |
EXPOSURE VIA SKIN CONTACT |
2 |
0.0001 |
| 737 |
NODULE |
1 |
0.0001 |
| 738 |
INCORRECT PRODUCT STORAGE |
1 |
0.0001 |
| 739 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
3 |
0.0001 |
| 740 |
BRADYCARDIA |
4 |
0.0001 |
| 741 |
EAR INFECTION |
2 |
0.0001 |
| 742 |
HAIR TEXTURE ABNORMAL |
1 |
0.0001 |
| 743 |
THROMBOSIS |
6 |
0.0001 |
| 744 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 745 |
PRODUCT USE ISSUE |
14 |
0.0001 |
| 746 |
SINUS CONGESTION |
1 |
0.0001 |
| 747 |
THROAT TIGHTNESS |
2 |
0.0001 |
| 748 |
HYPOAESTHESIA |
11 |
0.0001 |
| 749 |
GINGIVAL BLEEDING |
1 |
0.0001 |
| 750 |
LUNG NEOPLASM MALIGNANT |
3 |
0.0001 |
| 751 |
CONDITION AGGRAVATED |
22 |
0.0001 |
| 752 |
ACUTE KIDNEY INJURY |
11 |
0.0001 |
| 753 |
BLOOD TEST ABNORMAL |
1 |
0.0001 |
| 754 |
INCORRECT DRUG ADMINISTRATION DURATION |
2 |
0.0001 |
| 755 |
DISSEMINATED INTRAVASCULAR COAGULATION |
1 |
0.0001 |
| 756 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 757 |
HEART RATE INCREASED |
7 |
0.0001 |
| 758 |
FLATULENCE |
4 |
0.0001 |
| 759 |
DIALYSIS |
1 |
0.0001 |
| 760 |
INTERNATIONAL NORMALISED RATIO INCREASED |
2 |
0.0001 |
| 761 |
INCORRECT DOSE ADMINISTERED |
16 |
0.0001 |
| 762 |
BRONCHOSPASM |
1 |
0.0001 |
| 763 |
CARDIOGENIC SHOCK |
1 |
0.0001 |
| 764 |
ASTHENIA |
26 |
0.0001 |
| 765 |
MYELODYSPLASTIC SYNDROME |
1 |
0.0001 |
| 766 |
HYPERTHYROIDISM |
1 |
0.0001 |
| 767 |
DECREASED APPETITE |
16 |
0.0001 |
| 768 |
ANAEMIA |
13 |
0.0001 |
| 769 |
ANGIOEDEMA |
3 |
0.0001 |
| 770 |
PSYCHOTIC DISORDER |
2 |
0.0001 |
| 771 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 772 |
IMMUNODEFICIENCY |
1 |
0.0001 |
| 773 |
DEVICE ISSUE |
6 |
0.0001 |
| 774 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 775 |
HYPERTENSION |
14 |
0.0001 |
| 776 |
BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 777 |
DEVICE FAILURE |
1 |
0.0001 |
| 778 |
MUSCLE SPASMS |
12 |
0.0001 |
| 779 |
INJECTION SITE PAIN |
20 |
0.0001 |
| 780 |
DRUG ADMINISTRATION ERROR |
2 |
0.0001 |
| 781 |
ADVERSE EVENT |
6 |
0.0001 |
| 782 |
PHARYNGEAL OEDEMA |
1 |
0.0001 |
| 783 |
CHEST PAIN |
12 |
0.0001 |
| 784 |
HYPERSENSITIVITY |
12 |
0.0001 |
| 785 |
DELUSION |
1 |
0.0001 |
| 786 |
INSOMNIA |
17 |
0.0001 |
| 787 |
DRUG-INDUCED LIVER INJURY |
2 |
0.0001 |
| 788 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 789 |
HYPOTHYROIDISM |
2 |
0.0001 |
| 790 |
HYPOGLYCAEMIA |
3 |
0.0001 |
| 791 |
BLOOD POTASSIUM INCREASED |
1 |
0.0001 |
| 792 |
MANIA |
1 |
0.0001 |
| 793 |
PYREXIA |
21 |
0.0001 |
| 794 |
BACK PAIN |
14 |
0.0001 |
| 795 |
CYTOMEGALOVIRUS INFECTION |
1 |
0.0001 |
| 796 |
DEHYDRATION |
8 |
0.0001 |
| 797 |
PERICARDITIS |
1 |
0.0001 |
| 798 |
TYPE 2 DIABETES MELLITUS |
2 |
0.0001 |
| 799 |
DRUG INEFFECTIVE |
78 |
0.0001 |
| 800 |
HEMIPARESIS |
1 |
0.0001 |
| 801 |
METRORRHAGIA |
1 |
0.0001 |
| 802 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 803 |
MULTI-ORGAN FAILURE |
1 |
0.0001 |
| 804 |
LOCAL SWELLING |
1 |
0.0001 |
| 805 |
MUSCULOSKELETAL PAIN |
3 |
0.0001 |
| 806 |
METASTASES TO LIVER |
1 |
0.0001 |
| 807 |
DERMATITIS ATOPIC |
3 |
0.0001 |
| 808 |
COLD SWEAT |
1 |
0.0001 |
| 809 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
2 |
0.0001 |
| 810 |
PANIC ATTACK |
2 |
0.0001 |
| 811 |
ACCIDENTAL OVERDOSE |
2 |
0.0001 |
| 812 |
FEELING ABNORMAL |
13 |
0.0001 |
| 813 |
URTICARIA |
9 |
0.0001 |
| 814 |
NECK PAIN |
3 |
0.0001 |
| 815 |
SWELLING |
5 |
0.0001 |
| 816 |
OXYGEN SATURATION DECREASED |
3 |
0.0001 |
| 817 |
MYALGIA |
9 |
0.0001 |
| 818 |
HYPOCALCAEMIA |
1 |
0.0001 |
| 819 |
FRACTURE |
1 |
0.0001 |
| 820 |
GASTRIC ULCER |
1 |
0.0001 |
| 821 |
PROTEINURIA |
1 |
0.0001 |
| 822 |
MUSCULOSKELETAL DISORDER |
1 |
0.0001 |
| 823 |
INCREASED APPETITE |
1 |
0.0001 |
| 824 |
HAEMORRHOIDS |
1 |
0.0001 |
| 825 |
CHILLS |
6 |
0.0001 |
| 826 |
NASAL CONGESTION |
3 |
0.0001 |
| 827 |
DYSPEPSIA |
5 |
0.0001 |
| 828 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
1 |
0.0001 |
| 829 |
ABNORMAL BEHAVIOUR |
2 |
0.0001 |
| 830 |
DISORIENTATION |
2 |
0.0001 |
| 831 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 832 |
PRESCRIBED UNDERDOSE |
1 |
0.0001 |
| 833 |
BONE MARROW FAILURE |
1 |
0.0000 |
| 834 |
ANXIETY |
14 |
0.0000 |
| 835 |
ABDOMINAL PAIN UPPER |
10 |
0.0000 |
| 836 |
RHABDOMYOLYSIS |
2 |
0.0000 |
| 837 |
POLLAKIURIA |
2 |
0.0000 |
| 838 |
RENAL IMPAIRMENT |
4 |
0.0000 |
| 839 |
FATIGUE |
37 |
0.0000 |
| 840 |
MOUTH ULCERATION |
1 |
0.0000 |
| 841 |
JOINT INJURY |
1 |
0.0000 |
| 842 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 843 |
HYPERHIDROSIS |
6 |
0.0000 |
| 844 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
0.0000 |
| 845 |
AMNESIA |
3 |
0.0000 |
| 846 |
SWELLING FACE |
3 |
0.0000 |
| 847 |
BLOOD CREATININE INCREASED |
3 |
0.0000 |
| 848 |
LIVER DISORDER |
2 |
0.0000 |
| 849 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 850 |
THROMBOCYTOPENIA |
5 |
0.0000 |
| 851 |
PULMONARY OEDEMA |
2 |
0.0000 |
| 852 |
ASTHMA |
5 |
0.0000 |
| 853 |
DIZZINESS |
22 |
0.0000 |
| 854 |
SUICIDAL IDEATION |
4 |
0.0000 |
| 855 |
OROPHARYNGEAL PAIN |
4 |
0.0000 |
| 856 |
BURNING SENSATION |
3 |
0.0000 |
| 857 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
2 |
0.0000 |
| 858 |
DIABETIC KETOACIDOSIS |
1 |
0.0000 |
| 859 |
CEREBROVASCULAR ACCIDENT |
7 |
0.0000 |
| 860 |
RESPIRATORY FAILURE |
3 |
0.0000 |
| 861 |
ARTHRALGIA |
17 |
0.0000 |
| 862 |
PAIN |
25 |
0.0000 |
| 863 |
ABASIA |
1 |
0.0000 |
| 864 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 865 |
UNEVALUABLE EVENT |
3 |
0.0000 |
| 866 |
BLOOD PRESSURE INCREASED |
6 |
0.0000 |
| 867 |
HOSPITALISATION |
6 |
0.0000 |
| 868 |
SINUSITIS |
4 |
0.0000 |
| 869 |
DIARRHOEA |
25 |
0.0000 |
| 870 |
SEDATION |
1 |
0.0000 |
| 871 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
1 |
0.0000 |
| 872 |
JAUNDICE |
1 |
0.0000 |
| 873 |
DISTURBANCE IN ATTENTION |
2 |
0.0000 |
| 874 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 875 |
RASH PRURITIC |
2 |
0.0000 |
| 876 |
PRODUCT QUALITY ISSUE |
5 |
0.0000 |
| 877 |
CONSTIPATION |
8 |
0.0000 |
| 878 |
INFLUENZA LIKE ILLNESS |
3 |
0.0000 |
| 879 |
VISION BLURRED |
5 |
0.0000 |
| 880 |
DIVERTICULITIS |
1 |
0.0000 |
| 881 |
MEDICATION ERROR |
2 |
0.0000 |
| 882 |
FEELING COLD |
1 |
0.0000 |
| 883 |
INFLUENZA |
4 |
0.0000 |
| 884 |
WEIGHT DECREASED |
10 |
0.0000 |
| 885 |
EYE PAIN |
2 |
0.0000 |
| 886 |
MUSCULAR WEAKNESS |
4 |
0.0000 |
| 887 |
RASH |
15 |
0.0000 |
| 888 |
PRODUCT STORAGE ERROR |
3 |
0.0000 |
| 889 |
DYSSTASIA |
1 |
0.0000 |
| 890 |
MUSCULOSKELETAL STIFFNESS |
3 |
0.0000 |
| 891 |
SURGERY |
2 |
0.0000 |
| 892 |
ERYTHEMA |
7 |
0.0000 |
| 893 |
PAIN IN EXTREMITY |
10 |
0.0000 |
| 894 |
IRRITABILITY |
2 |
0.0000 |
| 895 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 896 |
HEPATIC FAILURE |
1 |
0.0000 |
| 897 |
SUICIDE ATTEMPT |
2 |
0.0000 |
| 898 |
OEDEMA PERIPHERAL |
4 |
0.0000 |
| 899 |
FEELING HOT |
2 |
0.0000 |
| 900 |
PERIPHERAL SWELLING |
5 |
0.0000 |
| 901 |
VISUAL IMPAIRMENT |
4 |
0.0000 |
| 902 |
BONE DENSITY DECREASED |
1 |
0.0000 |
| 903 |
BLOOD PRESSURE DECREASED |
2 |
0.0000 |
| 904 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 905 |
NEOPLASM MALIGNANT |
2 |
0.0000 |
| 906 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 907 |
SLEEP DISORDER |
2 |
0.0000 |
| 908 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 909 |
MOBILITY DECREASED |
2 |
0.0000 |
| 910 |
NASOPHARYNGITIS |
5 |
0.0000 |
| 911 |
INJECTION SITE MASS |
1 |
0.0000 |
| 912 |
DYSARTHRIA |
1 |
0.0000 |
| 913 |
ACNE |
2 |
0.0000 |
| 914 |
PRURITUS |
10 |
0.0000 |
| 915 |
COUGH |
7 |
0.0000 |
| 916 |
HYPOTENSION |
5 |
0.0000 |
| 917 |
CARDIAC FAILURE |
2 |
0.0000 |
| 918 |
PNEUMONIA |
8 |
0.0000 |
| 919 |
BLINDNESS |
1 |
0.0000 |
| 920 |
FALL |
8 |
0.0000 |
| 921 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 922 |
HYPOACUSIS |
1 |
0.0000 |
| 923 |
SEPTIC SHOCK |
1 |
0.0000 |
| 924 |
MENTAL DISORDER |
1 |
0.0000 |
| 925 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 926 |
RENAL FAILURE |
3 |
0.0000 |
| 927 |
DRY SKIN |
3 |
0.0000 |
| 928 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 929 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 930 |
DYSPHAGIA |
2 |
0.0000 |
| 931 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 932 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 933 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 934 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 935 |
CONTUSION |
2 |
0.0000 |
| 936 |
INFECTION |
3 |
0.0000 |
| 937 |
DRUG INTOLERANCE |
2 |
0.0000 |
| 938 |
LUNG DISORDER |
1 |
0.0000 |
| 939 |
ALOPECIA |
4 |
0.0000 |
| 940 |
AGGRESSION |
1 |
0.0000 |
| 941 |
CELLULITIS |
1 |
0.0000 |
| 942 |
ILLNESS |
2 |
0.0000 |
| 943 |
PLATELET COUNT DECREASED |
2 |
0.0000 |
| 944 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 945 |
CONFUSIONAL STATE |
3 |
0.0000 |
| 946 |
OVERDOSE |
4 |
0.0000 |
| 947 |
BLISTER |
1 |
0.0000 |
| 948 |
URINARY TRACT INFECTION |
3 |
0.0000 |
| 949 |
DEPRESSION |
4 |
0.0000 |
| 950 |
LETHARGY |
1 |
0.0000 |
| 951 |
DYSPHONIA |
1 |
0.0000 |
| 952 |
BONE PAIN |
1 |
0.0000 |
| 953 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
3 |
0.0000 |
| 954 |
JOINT SWELLING |
2 |
0.0000 |
| 955 |
NO ADVERSE EVENT |
3 |
0.0000 |
| 956 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 957 |
DEVICE EXPULSION |
1 |
0.0000 |
| 958 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
| 959 |
DEVICE DIFFICULT TO USE |
1 |
0.0000 |
| 960 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
3 |
0.0000 |
| 961 |
NEUTROPENIA |
2 |
0.0000 |
| 962 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 963 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 964 |
AGITATION |
1 |
0.0000 |
| 965 |
BRONCHITIS |
1 |
0.0000 |
| 966 |
DYSGEUSIA |
1 |
0.0000 |
| 967 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 968 |
ARTHRITIS |
1 |
0.0000 |
| 969 |
TREMOR |
2 |
0.0000 |
| 970 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 971 |
BALANCE DISORDER |
1 |
0.0000 |
| 972 |
MYOCARDIAL INFARCTION |
2 |
0.0000 |
| 973 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 974 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 975 |
CARDIAC DISORDER |
1 |
0.0000 |
| 976 |
BLOOD GLUCOSE INCREASED |
2 |
0.0000 |
| 977 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 978 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 979 |
PRODUCT DOSE OMISSION ISSUE |
3 |
0.0000 |
| 980 |
FLUSHING |
1 |
0.0000 |
| 981 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 982 |
SEPSIS |
1 |
0.0000 |
| 983 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 984 |
PSORIASIS |
1 |
0.0000 |
| 985 |
COVID-19 |
1 |
0.0000 |
| 986 |
DEATH |
2 |
0.0000 |